These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26450707)

  • 21. Imiquimod in dermatology: an overview.
    Hanna E; Abadi R; Abbas O
    Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local reactions to imiquimod in the treatment of basal cell carcinoma.
    Tandon Y; Brodell RT
    Dermatol Online J; 2012 Sep; 18(9):1. PubMed ID: 23031368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of imiquimod in the treatment of periocular tumours.
    Ross AH; Kennedy CT; Collins C; Harrad RA
    Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 25. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
    Harting M; Vujevich J; Goldberg LH
    Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma.
    Newman MD; Weinberg JM
    Cutis; 2007 Apr; 79(4 Suppl):18-28. PubMed ID: 17508492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
    Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
    Sriprakash K; Godbolt A
    Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
    Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
    Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imiquimod: in superficial basal cell carcinoma.
    Oldfield V; Keating GM; Perry CM
    Am J Clin Dermatol; 2005; 6(3):195-200; discussion 201-2. PubMed ID: 15943496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
    Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
    Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
    Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
    J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
    Marks R; Gebauer K; Shumack S; Amies M; Bryden J; Fox TL; Owens ML;
    J Am Acad Dermatol; 2001 May; 44(5):807-13. PubMed ID: 11312429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imiquimod in basal cell carcinoma: how does it work?
    Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
    Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
    Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
    J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential treatment of giant basal cell carcinomas.
    Madan V; West CA; Murphy JV; Lear JT
    J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
    Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
    Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.